Joseph Timothy Marakovits

This inventor holds 20 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Agouron Pharmaceuticals, Inc., Samumed, LLC, Biosplice Therapeutics, Inc.. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Timothy Marakovits. Retrieved from https://idiyas.com/inventor/joseph-timothy-marakovits

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 3)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 7.1

ph-index = 6

Forward Citations = 69(Granted Patents)

Company Filing History:

10 out of 174

Agouron Pharmaceuticals, Inc.

Biosplice Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

Areas of Expertise:

Pyrrolo[2,1-f][1,2,4]triazines

Isoquinolin-3-YL Carboxamides

Pyrazolo[4,3-B]Pyridines

Kinase Inhibitors

Antipicornaviral Compounds

Tricyclic Inhibitors

Poly(ADP-Ribose) Polymerases

Pharmaceutical Uses

Synthesis Materials

Therapeutic Uses

Compositions

Preparation Methods

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12134625 - Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof (2024-11-05),

2. 11673881 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2023-06-13),

3. 11174244 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2021-11-16),

4. 10556885 - Isoquinolin-3-YL carboxamides and preparation and use thereof (2020-02-11),

5. 10508099 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2019-12-17),

6. 10392383 - 3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof (2019-08-27),

7. 10329309 - 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof (2019-06-25),

8. 10287267 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2019-05-14),

9. 10195185 - 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof (2019-02-05),

10. 10188634 - 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof (2019-01-29),

11. 8530652 - Pyrrolopyrazoles, potent kinase inhibitors (2013-09-10),

12. 8067591 - Pyrrolopyrazole, potent kinase inhibitors (2011-11-29),

13. 6995142 - Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis (2006-02-07),

14. 6906198 - Antipicornaviral compounds, their preparation and use (2005-06-14),

15. 6548494 - Tricyclic inhibitors of poly(ADP-ribose) polymerases (2003-04-15),

Title: Innovations and Contributions of Joseph Timothy Marakovits

Introduction: Joseph Timothy Marakovits is an esteemed inventor based in Encinitas, California. With a remarkable portfolio of 20 patents, his work primarily focuses on developing therapeutic compounds aimed at treating various diseases. His contributions to the field of medicinal chemistry have made a significant impact on both research and clinical applications.

Latest Patents: Among his latest innovations, Marakovits has developed two notable patents. The first is related to Pyrrolo[2,1-f][1,2,4]triazines, which highlights the preparation and uses of these compounds in treating diseases characterized by overexpression of DYRK1A. These disorders include cancer, Down syndrome, Alzheimer's disease, diabetes, viral infections, and osteoarthritis. The second patent pertains to Isoquinolin-3-yl carboxamides, focusing on treating various conditions linked to the Wnt pathway signaling activation. This has implications for diseases such as cancer, abnormal cellular proliferation, angiogenesis, and several neurological conditions linked to DYRK1A overexpression.

Career Highlights: Throughout his career, Marakovits has worked with influential organizations, including Agouron Pharmaceuticals, Inc. and Samumed, LLC. His roles in these companies have allowed him to contribute significantly to pharmaceutical developments and innovations within the biomedical field.

Collaborations: Marakovits has collaborated with distinguished colleagues such as Sunil Kumar KC and Chandramouli Chiruta. These partnerships have fostered a collaborative environment aimed at advancing research and addressing critical health challenges.

Conclusion: Joseph Timothy Marakovits stands out as a pioneering inventor whose innovative patents and collaborations have the potential to shape the future of drug development. His work in creating compounds aimed at treating serious medical conditions underscores the importance of innovation in improving healthcare outcomes. Through his contributions, Marakovits continues to be a valuable asset in the field of medicinal research and development.

Profile summary based on public USPTO records.